[INFO] Processing sample 29
[INFO] Step 1. Single-Agent Few-shot Preparation
[INFO] Step 2. Single-Agent Final Decision
[INFO] Final decision: {0.3: "Let's analyze the options step by step in relation to increasing insulin sensitivity.\n\n1. **Glucagon (B)**: Glucagon primarily raises blood glucose levels by promoting gluconeogenesis and glycogenolysis in the liver. It does not increase insulin sensitivity; in fact, it can have the opposite effect.\n\n2. **Peroxisome proliferator-activated receptor gamma (D)**: PPAR-gamma is a nuclear receptor that plays a significant role in the regulation of glucose and lipid metabolism. It is involved in adipocyte differentiation and has been shown to improve insulin sensitivity, particularly in the context of thiazolidinedione medications (which are PPAR-gamma agonists). This option is likely to increase insulin sensitivity.\n\n3. **TNF-alpha (E)**: Tumor necrosis factor-alpha is a pro-inflammatory cytokine that is associated with insulin resistance. High levels of TNF-alpha are linked to decreased insulin sensitivity, so this option would not be correct.\n\n4. **Catecholamines (A)**: Catecholamines (like epinephrine and norepinephrine) can increase blood glucose levels and promote insulin resistance, especially during stress responses. They do not increase insulin sensitivity.\n\n5. **Glucocorticoids (C)**: Glucocorticoids (like cortisol) promote gluconeogenesis and can lead to insulin resistance, so they do not increase insulin sensitivity.\n\nBased on this analysis, the correct answer is:\n\n**Answer: (D) Peroxisome proliferator-activated receptor gamma**"}

[INFO] API calls for this sample: 5

[INFO] Sample 29 completed successfully